RAVULIZUMAB (Ultomiris®)

Clinical Indication

Paroxysmal nocturnal haemoglobinuria


In line with NICE TA698 this product should be used by specialist centres only. At the time of classification LLR is not a site of a specialist centre.

Date of classification

August 2019

Review date

July 2021


Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.